학술논문
1488P Exploring efficacy and safety of immune checkpoint inhibitors (ICI) in extensive stage (ES)- small-cell lung cancer (SCLC) in specific populations: Real-world data from the Durvalumab Expanded Access program Regional European cohort (DEAR)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S840-S840
Subject
Language
ISSN
0923-7534